Key result
Atrial fibrillation is primarily triggered by ectopic foci in the pulmonary veins and sustained by structural remodeling and atrial fibrosis, which serve as emerging targets for novel therapies.
Design
Review
Authors
Loading...
May guide upstream AF therapy development targeting fibrosis; leaves open randomized validation before clinical adoption.
This review highlights the complex pathophysiology of atrial fibrillation, emphasizing the interplay between triggers, structural/electrical remodeling, and modifiers, which opens avenues for novel upstream therapies.
Aldhoon et al. (2010) conducted a review in Atrial Fibrillation. Atrial fibrillation is primarily triggered by ectopic foci in the pulmonary veins and sustained by structural remodeling and atrial fibrosis, which serve as emerging targets for novel therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: